| 4 | Statement of changes in beneficial owner... | Smith Scott Thomas | Latham & Watkins Llp (filing Agent) /fa | 06/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 06/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Smith Scott Thomas | Latham & Watkins Llp (filing Agent) /fa | 06/01/2026 | |
| 4 | Statement of changes in beneficial owner... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 06/01/2026 | |
| 3/A | Amendment to the Initial statement of be... | Smith Scott Thomas | Latham & Watkins Llp (filing Agent) /fa | 06/01/2026 | |
| 3/A | Amendment to the Initial statement of be... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 06/01/2026 | |
| 3 | Initial statement of beneficial ownershi... | Smith Scott Thomas | Latham & Watkins Llp (filing Agent) /fa | 03/18/2026 | |
| 3 | Initial statement of beneficial ownershi... | Ascendis Pharma A/s | Latham & Watkins Llp (filing Agent) /fa | 03/18/2026 | |
| 144 | Filing for proposed sale of securities u... | Smith Scott Thomas | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/12/2025 | |
| 144 | Filing for proposed sale of securities u... | Ascendis Pharma A/s | Merrill Lynch, Pierce, Fenner & Smith Inc/pes/fa | 08/12/2025 | |
| Load More |
